MEDICO — Medico Remedies Share Price
- IN₹4.82bn
- IN₹4.92bn
- IN₹1.45bn
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 8.38 | ||
Price to Tang. Book | 8.4 | ||
Price to Free Cashflow | 1,965.26 | ||
Price to Sales | 3.08 | ||
EV to EBITDA | 36.6 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 17.72% | ||
Return on Equity | 17.17% | ||
Operating Margin | 6.61% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | 886.36 | 1,223.86 | 1,210.2 | 1,404.37 | 1,449.21 | n/a | n/a | 8.21% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +3.68 | +536.52 | -52.83 | +48.09 | +14.49 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Medico Remedies Limited is an India-based company, principally engaged in the pharmaceutical business. The Company is involved in the development, manufacture and sale of pharmaceutical and nutraceutical products. It focuses on anti-infective, Beta-Lactams, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, hematinic and other supplements. The Company also manufactures and markets capabilities in other drugs such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Pediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup, among others. Its syrups include Medivit Syrup and Ferrovit Syrup.
Directors
- Haresh Mehta CHM (62)
- Harshit Mehta MDR (32)
- Rishit Mehta EDR (29)
- Rita Mehta EDR (56)
- Gopal Jha OTH
- Priyal Mehta OTH
- Dushant Pandey OTH
- Dinesh Modi SEC
- Bharat Rathod NID (57)
- Ramesh Rughani NID (66)
- Deepak Vekaria NID (60)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 18th, 1994
- Public Since
- February 8th, 2018
- No. of Employees
- 193
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
National Stock Exchange of India
- Shares in Issue
- 82,984,000

- Address
- 1105/1106, 11Th Floor, Hubtown Solaris,, THANE, 401404
- Web
- https://www.medicoremediesindia.com/
- Phone
- +91 8046047706
- Auditors
- V J Shah & Co
Upcoming Events for MEDICO
Q1 2026 Medico Remedies Ltd Earnings Release
Medico Remedies Ltd Annual Shareholders Meeting
Similar to MEDICO
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
As of Today at 21:58 UTC, shares in Medico Remedies are trading at IN₹56.08. This share price information is delayed by 15 minutes.
Shares in Medico Remedies last closed at IN₹56.08 and the price had moved by +19.96% over the past 365 days. In terms of relative price strength the Medico Remedies share price has outperformed the S&P BSE 100 Index by +13% over the past year.
There is no consensus recommendation for this security.
Find out moreMedico Remedies does not currently pay a dividend.
Medico Remedies does not currently pay a dividend.
Medico Remedies does not currently pay a dividend.
To buy shares in Medico Remedies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹56.08, shares in Medico Remedies had a market capitalisation of IN₹4.82bn.
Here are the trading details for Medico Remedies:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: MEDICO
Based on an overall assessment of its quality, value and momentum Medico Remedies is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medico Remedies. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +16.11%.
As of the last closing price of IN₹56.08, shares in Medico Remedies were trading +7.13% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Medico Remedies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹56.08.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Medico Remedies' management team is headed by:
- Haresh Mehta - CHM
- Harshit Mehta - MDR
- Rishit Mehta - EDR
- Rita Mehta - EDR
- Gopal Jha - OTH
- Priyal Mehta - OTH
- Dushant Pandey - OTH
- Dinesh Modi - SEC
- Bharat Rathod - NID
- Ramesh Rughani - NID
- Deepak Vekaria - NID